Carlson Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,026,000
Closed -$91.4M 317
2017
Q1
$91.4M Buy
+1,026,000
New +$84.4M 1.16% 17
2016
Q2
Sell
-172,525
Closed -$14.7M 352
2016
Q1
$14.7M Buy
+172,525
New +$12.8M 0.18% 162
2015
Q4
Sell
-351,325
Closed -$24.7M 385
2015
Q3
$24.7M Sell
351,325
-263,950
-43% -$21.7M 0.28% 112
2015
Q2
$55.5M Buy
615,275
+407,980
+197% +$39.3M 0.61% 50
2015
Q1
$20.8M Buy
+207,295
New +$20.9M 0.23% 142
2014
Q4
Sell
-218,109
Closed -$21M 403
2014
Q3
$21M Buy
218,109
+85,219
+64% +$8.07M 0.23% 148
2014
Q2
$12.4M Buy
+132,890
New +$11.6M 0.14% 217
2013
Q3
Sell
-148,070
Closed -$11.7M 335
2013
Q2
$11.7M Buy
+148,070
New +$11.9M 0.14% 209

Other funds holding MJN

Carlson Capital's MJN Position: Q2 2017 in Review

Carlson Capital sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,026,000 shares — an estimated $91.4M sold.

Carlson Capital first reported a position in MJN in Q2 2013 and held it in 8 quarters. The position peaked at $91.4M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Carlson Capital reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Carlson Capital sold 1,026,000 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $91.4M.
  • Carlson Capital first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 8 quarters.
  • Carlson Capital's Mead Johnson Nutrition Company position peaked at $91.4M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Carlson Capital's 13F filing for Q2 2017, filed 14 Aug 2017.